Literature DB >> 10395747

Peptide aldehyde inhibitors of bacterial peptide deformylases.

D J Durand1, B Gordon Green, J F O'Connell, S K Grant.   

Abstract

Bacterial peptide deformylases (PDF, EC 3.5.1.27) are metalloenzymes that cleave the N-formyl groups from N-blocked methionine polypeptides. Peptide aldehydes containing a methional or norleucinal inhibited recombinant peptide deformylase from gram-negative Escherichia coli and gram-positive Bacillus subtilis. The most potent inhibitor was calpeptin, N-CBZ-Leu-norleucinal, which was a competitive inhibitor of the zinc-containing metalloenzymes, E. coli and B. subtilis PDF with Ki values of 26.0 and 55.6 microM, respectively. Cobalt-substituted E. coli and B. subtilis deformylases were also inhibited by these aldehydes with Ki values for calpeptin of 9.5 and 12.4 microM, respectively. Distinct spectral changes were observed upon binding of calpeptin to the Co(II)-deformylases, consistent with the noncovalent binding of the inhibitor rather than the formation of a covalent complex. In contrast, the chelator 1,10-phenanthroline caused the time-dependent inhibition of B. subtilis Co(II)-PDF activity with the loss of the active site metal. The fact that calpeptin was nearly equipotent against deformylases from both gram-negative and gram-positive bacterial sources lends further support to the idea that a single deformylase inhibitor might have broad-spectrum antibacterial activity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395747     DOI: 10.1006/abbi.1999.1274

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.

Authors:  J M Clements; R P Beckett; A Brown; G Catlin; M Lobell; S Palan; W Thomas; M Whittaker; S Wood; S Salama; P J Baker; H F Rodgers; V Barynin; D W Rice; M G Hunter
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Eukaryotic peptide deformylases. Nuclear-encoded and chloroplast-targeted enzymes in Arabidopsis.

Authors:  L M Dirk; M A Williams; R L Houtz
Journal:  Plant Physiol       Date:  2001-09       Impact factor: 8.340

4.  Human mitochondrial peptide deformylase, a new anticancer target of actinonin-based antibiotics.

Authors:  Mona D Lee; Yuhong She; Michael J Soskis; Christopher P Borella; Jeffrey R Gardner; Paula A Hayes; Benzon M Dy; Mark L Heaney; Mark R Philips; William G Bornmann; Francis M Sirotnak; David A Scheinberg
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

5.  Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.

Authors:  Huamei Fu; Claes Dahlgren; Johan Bylund
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

6.  N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.

Authors:  Corinne J Hackbarth; Dawn Z Chen; Jason G Lewis; Kirk Clark; James B Mangold; Jeffrey A Cramer; Peter S Margolis; Wen Wang; Jim Koehn; Charlotte Wu; S Lopez; George Withers; Helen Gu; Elina Dunn; R Kulathila; Shi-Hao Pan; Wilma L Porter; Jeff Jacobs; Joaquim Trias; Dinesh V Patel; Beat Weidmann; Richard J White; Zhengyu Yuan
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.